Myoglobinuria
For patient information, click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aksiniya Stevasarova, M.D.; Venkata Sivakrishna Kumar Pulivarthi M.B.B.S [2]
Overview
Myoglobinuria is the presence of myoglobin in the urine, usually associated with rhabdomyolysis or muscle destruction. Myoglobin (Mb or MB) is an iron- and oxygen-binding protein found in muscles. Myoglobin is present in muscle cells as a reserve of oxygen.In humans, myoglobin is only found in the bloodstream after muscle injury. It is an abnormal finding, and can be diagnostically relevant when found in blood.[1] Myoglobin is the primary oxygen-carrying pigment of muscle tissues.[2] High concentrations of myoglobin in muscle cells allow organisms to hold their breath for a longer period of time. Diving mammals such as whales and seals have muscles with particularly high abundance of myoglobin.[1] Myoglobin is found in Type I muscle, Type II A and Type II B, but most texts consider myoglobin not to be found in smooth muscle.
References
- ↑ 1.0 1.1 Nelson DL, Cox MM (2000). Lehninger Principles of Biochemistry (3rd ed.). New York: Worth Publishers. p. 206. ISBN 0-7167-6203-X. (Google books link is the 2008 edition)
- ↑ Ordway GA, Garry DJ (Sep 2004). “Myoglobin: an essential hemoprotein in striated muscle”. The Journal of Experimental Biology. 207 (Pt 20): 3441–6. doi:10.1242/jeb.01172. PMID 15339940.
Historical Perspective
Discovery
- In 1958 John Kendrew and associates announced that they have discovered that Myoglobin was the first protein to have its three-dimensional structure revealed by X-ray crystallography.[1] .[2]
- For this discovery, John Kendrew shared the 1962 Nobel Prize in chemistry with Max Perutz.[3]
Landmark Events in the Development of Treatment Strategies
- Despite being one of the most studied proteins in biology, its physiological function is not yet conclusively established: mice genetically engineered to lack myoglobin can be viable and fertile but show many cellular and physiological adaptations to overcome the loss. Through observing these changes in myoglobin-deplete mice, it is hypothesised that myoglobin function relates to increased oxygen transport to muscle, oxygen storage and as a scavenger of reactive oxygen species.[4]
References
- ↑ (U.S.) National Science Foundation: Protein Data Bank Chronology (Jan. 21, 2004). Retrieved 3.17.2010
- ↑ Kendrew JC, Bodo G, Dintzis HM, Parrish RG, Wyckoff H, Phillips DC (Mar 1958). “A three-dimensional model of the myoglobin molecule obtained by x-ray analysis”. Nature. 181 (4610): 662–6. Bibcode:1958Natur.181..662K. doi:10.1038/181662a0. PMID 13517261.
- ↑ The Nobel Prize in Chemistry 1962
- ↑ Garry DJ, Kanatous SB, Mammen PP (2007). “Molecular insights into the functional role of myoglobin”. Advances in Experimental Medicine and Biology. 618: 181–93. doi:10.1007/978-0-387-75434-5_14. PMID 18269197.
Classification
Myoglobin can take the forms of oxymyoglobin (MbO2), carboxymyoglobin (MbCO), and metmyoglobin (met-Mb), similarly to different forms of Hemoglobin – oxyhemoglobin (HbO2), carboxyhemoglobin (HbCO), and methemoglobin (met-Hb).
Pathophysiology
Normally myoglobin is filtered and excreted with the urine, but if too much myoglobin is released into the circulation from damaged muscle tissue (rhabdomyolysis), which has very high concentrations of myoglobin, it can be toxic to the renal tubular epithelium and so may cause acute kidney injury.[1] It is not the myoglobin itself that is toxic (it is a protoxin) but the ferrihemate portion that is dissociated from myoglobin in acidic environments (e.g., acidic urine, lysosomes).
Myoglobin is a sensitive marker for muscle injury, making it a potential marker for myocardial infarction in patients with chest pain.[2] However, elevated myoglobin has low specificity for acute myocardial infarction (AMI) and thus CK-MB, cardiac Troponin, ECG, and clinical signs should be taken into account to make the diagnosis.
References
- ↑ Naka T, Jones D, Baldwin I, Fealy N, Bates S, Goehl H, Morgera S, Neumayer HH, Bellomo R (Apr 2005). “Myoglobin clearance by super high-flux hemofiltration in a case of severe rhabdomyolysis: a case report”. Critical Care. 9 (2): R90–5. doi:10.1186/cc3034. PMC 1175920. PMID 15774055.
- ↑ Weber M, Rau M, Madlener K, Elsaesser A, Bankovic D, Mitrovic V, Hamm C (Nov 2005). “Diagnostic utility of new immunoassays for the cardiac markers cTnI, myoglobin and CK-MB mass”. Clinical Biochemistry. 38 (11): 1027–30. doi:10.1016/j.clinbiochem.2005.07.011. PMID 16125162.
Causes
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview=
The template of crowdiagnosis project is shown in this section and it can be copied for creating the causes page by going into the edit box.
- The overview section should include the disease name in the first sentence.
- The goal is to summarize the page in several sentences, and the section can be the same as the causes segment on the overview page.
- Confirm that the overview statement is in a text format and does not contain bullet points.
- Confirm that periods, commas and spaces are appropriately placed.
- Confirm that no text is bolded or italicized randomly in between the text.
- Make sure to check for spellings and grammatical errors thoroughly.
- Confirm that there are no floating periods and comas.
- Confirm that periods and comas are present before the start of references instead at the end to avoid floating periods and comas.
- Confirm that all the internal links work and there are no black links in between texts.
- Confirm that no links are created to same page.
- Make sure to create maximum internal links and for complete words, e.g,
- Ventricular tachycardia – [[Ventricular]] [[tachycardia]] – not recommended
- Ventricular tachycardia- [[Ventricular tachycardia]] – recommended
- To see an example, click here.
Template
- First Sentence:
- [Disease name] may be caused by either [cause1], [cause2], or [cause3].
- OR
- Life threatening causes of [symptom/manifestation] include [cause1], [cause2], and [cause3].
- OR
- [Cause] is a life threatening cause of [disease].
- OR
- Common causes of [disease name] include [cause1], [cause2], and [cause3].
- OR
- [Disease name] is caused by an infection with [pathogen name].
- OR
- [Pathogen name] infection is caused by [pathogen name], [description of pathogen].
- OR
- The cause of [disease name] has not been identified.
- OR
- There are no established causes for [disease name].
- OR
- [Disease name] is caused by a mutation in the [gene name] gene.
- OR
- Common causes of [disease name] include [cause1] and [cause2]. Less common causes of [disease name] include [cause 3], [cause 4], and [cause 5].
- Examples:
- Example 1: Focal segmental glomerulosclerosis of the kidneys may be caused by either genetic diseases, viruses, malignancies, or drugs.
- Example 2: Life threatening causes of chest pain include myocardial infarction, pulmonary embolism, tension pneumothorax, cardiac tamponade, esophageal rupture, and aortic dissection.
- Example 3: Esophageal perforation is a life-threatening cause of mediastinitis.
- Example 4: Common causes of neonatal meningitis include E. coli, Group B Steptococcus, and Listeria monocytogenes.
- Example 5: Legionellosis is caused by an infection with Legionella spp.
- Example 6: Clostridium difficile infection is caused by Clostridium difficile, a spore-forming, toxin-producing, obligate anaerobic, gram-positive bacillus.
- Example 7: The cause of acinic cell carcinoma has not been identified.
- Example 8: There are no established causes for acinic cell carcinoma.
- Example 9: Retinoblastoma is caused by a mutation in the RB1 gene.
- Example 10: Common causes of PID include Neisseria gonorrhoeae and Chlamydia trachomatis. Less common causes of PID include Bacteroides, Enterococci, Mycoplasma and Staphylococci.
- Additional Sentences:
- [Pathogen] belongs to the [pathogen family] family.
- OR
- [Pathogen] is a [feature1], [feature2], [feature3], gram-[positive/negative] [shape].
- OR
- Other causes of [disease name] include [cause 1], [cause 2], and [cause 3].
- Examples
- Example 1: Influenza belongs to the Orthomyxoviridae family.
- Example 2: C. difficile is a spore-forming, toxin-producing, obligate anaerobic, gram-positive bacillus.
- Example 3: Salmonella spp. is a motile, lactose-fermenting, facultative intracellular gram-negative rod.
- Example 4: Influenza is an enveloped, pleomorphic, segmented virus with a negative-sense, single-stranded RNA genome.
- Example 5: Other causes of PID include Bacteroides, Enterococci, Mycoplasma and Staphylococci.
Preferred Template Statements
IF there are life-threatening causes of the disease, list those first, followed by common causes, then less common causes.
- Life-threatening causes of [symptom/manifestation] include [cause1], [cause2], and [cause3].
- [Cause] is a life-threatening cause of [disease].
IF there are no life-threatening causes of the disease, begin with common causes. If no distinctions can be made between common and less-common causes, list all causes together.
- On the overview page, use a full sentence:
- Disease name] may be caused by [cause1], [cause2], or [cause3].
- Common causes of [disease] include [cause1], [cause2], and [cause3].
- The most common cause of [disease name] is [cause 1]. Less common causes of [disease name] include [cause 2], [cause 3], and [cause 4].
- On the Causes microchapter, use bullet points:
- [Disease name] may be caused by:
- [cause1]
- [cause2]
- [cause3]
- [Disease name] may be caused by:
IF the disease is caused by one specific pathogen:
- [Disease name] is caused by an infection with [pathogen name].
- [Pathogen name] infection is caused by [pathogen name].
IF the disease arises from a genetic mutation:
- [Disease name] is caused by a mutation in the [gene name] gene.
IF genetics play an unspecified role in the development of the disease:
IF the cause of the disease is unknown:
- The cause of [disease name] has not been identified. To review risk factors for the development of [disease name], click here.
Template
Life-threatening causes
Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated.
- Life threatening causes do not include chronic conditions.
- Make sure to include the following definition underneath the subheading of every life threatening causes section: Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated.
- The list of life threatening causes is arranged in alphabetical order.
- If the page’s disease is itself life-threatening, do not add causes in the life-threatening causes section. Instead, write the following sentence under the subheading: Disease name is a life-threatening condition and must be treated as such irrespective of the causes. Life-threatening conditions may result in death or permanent disability within 24 hours if left untreated.
Common causes
- This section is to outline the most common causes of the disease or condition you are describing.
- This can be done in a list form where causes are arranged in alphabetical order.
Less common causes
- This section is to outline the less common causes of the disease or condition you are describing.
- This can be done in a list form where causes are arranged in alphabetical order.
Causes by organ system
- To obtain the coding for the table seen below, click here. You need to copy the table content from the edit box, and paste it into the edit box.
- You can then list the causes by organ system. List the causes, separated by a comma under the appropriate category where it says “No underlying causes”. Erase “No underlying causes” if you are listing causes in that category.
- For an example of the causes by organ system table in a causes microchapter, click here.
| Cardiovascular | No underlying causes |
| Chemical/Poisoning | No underlying causes |
| Dental | No underlying causes |
| Dermatologic | No underlying causes |
| Drug Side Effect | No underlying causes |
| Ear Nose Throat | No underlying causes |
| Endocrine | No underlying causes |
| Environmental | No underlying causes |
| Gastroenterologic | No underlying causes |
| Genetic | No underlying causes |
| Hematologic | No underlying causes |
| Iatrogenic | No underlying causes |
| Infectious Disease | No underlying causes |
| Musculoskeletal/Orthopedic | No underlying causes |
| Neurologic | No underlying causes |
| Nutritional/Metabolic | No underlying causes |
| Obstetric/Gynecologic | No underlying causes |
| Oncologic | No underlying causes |
| Ophthalmologic | No underlying causes |
| Overdose/Toxicity | No underlying causes |
| Psychiatric | No underlying causes |
| Pulmonary | No underlying causes |
| Renal/Electrolyte | No underlying causes |
| Rheumatology/Immunology/Allergy | No underlying causes |
| Sexual | No underlying causes |
| Trauma | No underlying causes |
| Urologic | No underlying causes |
| Miscellaneous | No underlying causes |
Causes in alphabetical order
List the causes of the disease in alphabetical order.
- Cause 1
- Cause 2
- Cause 3
- Cause 4
- Cause 5
- Cause 6
- Cause 7
- Cause 8
- Cause 9
- Cause 10
Citing Sources
- References should be cited for the material that you have put on your page. Type in {{Reflist|2}}.This will generate your references in small font, in two columns, with links to the original article and abstract.
- For information on how to add references into your page, click here
References
Differentiating Myoglobinuria from other Diseases
After centrifuge, the serum of myologinuria is clear, where the serum of hemoglobinuria after centrifuge is pink.
| Centrifuse Result | |||||||||||||||||||||||||||||||||||||||||||
| Sediment Red | Supernatant Red | ||||||||||||||||||||||||||||||||||||||||||
| Hematuria | Dipstick heme | ||||||||||||||||||||||||||||||||||||||||||
| Negative | Positive | ||||||||||||||||||||||||||||||||||||||||||
| ❑ Beeturia ❑ Phenazopyridine ❑ Porphyria ❑ Other | ❑ Myoglobin ❑ Hemoglobin | ||||||||||||||||||||||||||||||||||||||||||
| Plasma color | |||||||||||||||||||||||||||||||||||||||||||
| Clear | Red | ||||||||||||||||||||||||||||||||||||||||||
| Myoglobinuria | Hemoglobinuria | ||||||||||||||||||||||||||||||||||||||||||
To go back to the main page, click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Charmaine Patel, M.D. [2]
Introduction to the Differentiating (Disease Name) From Other Diseases Page
- This chapter covers the process that is traditionally known as “differential diagnosis”.
- The page name should be “Differentiating (disease name) from other diseases”, with only the first letter of the title capitalized.
- Goal: To provide information on a systematic method of differentiating a given disease from other diseases that may present similarly.
- For an example of a microchapter on differentiating disease, click here.
- Search the disease database (http://diseasesdatabase.com/content.asp) to assure the content for this page is complete.
- As with all microchapter pages linking to the main page, at the top of the edit box put {{CMG}}, your name template, and the microchapter navigation template you created at the beginning.
- Remember to create links within Wikidoc by placing [[square brackets]] around key words which you want to link to other pages. Make sure you make your links as specific as possible. For example if a sentence contained the phrase anterior spinal artery syndrome, the link should be to anterior spinal artery syndrome not anterior or artery or syndrome. For more information on how to create links click here.
- Remember to follow the same format and capitalization of letters as outlined in the template below.
- You should include the name of the disease in the first sentence of every subsection.
Overview
- The overview section should include the disease name in the first sentence.
- The goal is to summarize the page several sentences, usually stating the categories that the disease is classified by.
- This section can be the same as the differentiating disease section in the overview page.
Template
- First Sentence:
- [Disease name] must be differentiated from other diseases that cause [clinical feature 1], [clinical feature 2], and [clinical feature 3], such as [differential dx1], [differential dx2], and [differential dx3].
- OR
- [Disease name] must be differentiated from [[differential dx1], [differential dx2], and [differential dx3].
- OR
- [Disease name] must be differentiated from other causes of [symptom/sign], such as [Differential 1], [Differential 2], and [Differential 3].
- Examples:
- Example 1: Hepatitis C must be differentiated from other diseases that cause hepatic injury and abnormal liver function tests, such as other viral hepatitides (Hepatitis A, Hepatitis B, and Hepatitis E), alcoholic liver disease, non-alcoholic steatohepatitis, drug-induced liver injury, autoimmune hepatitis, and hepatocellular carcinoma.
- Example 2: Colorectal cancer must be differentiated from other diseases that cause unexplained weight loss, unexplained loss of appetite, abdominal discomfort, nausea, vomiting, diarrhea, anemia, and fatigue, such as irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), hemorrhoids, anal fissures, and diverticular disease.
- Example 3: Colorectal cancer must be differentiated from Irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), hemorrhoids, anal fissures, and diverticular disease.
- Example 4: Pericarditis must be differentiated from other causes of chest pain, such as myocardial infarction, aortic dissection, and pulmonary embolism.
Preferred Template Statements
- [Disease name] must be differentiated from other diseases that cause [clinical feature 1], [clinical feature 2], and [clinical feature 3], such as [differential dx1], [differential dx2], and [differential dx3].
- [Disease name] must be differentiated from [[differential dx1], [differential dx2], and [differential dx3].
IF the disease has multiple subtypes and the subtypes do not have the same differential diagnoses:
- As [disease name] manifests in a variety of clinical forms, differentiation must be established in accordance with the particular subtype. [Subtype name 1] must be differentiated from other diseases that cause [clinical feature 1], such as [differential dx1] and [differential dx2]. In contrast, [subtype name 2] must be differentiated from other diseases that cause [clinical feature 2], such as [differential dx3] and [differential dx4].
Differentiating (Disease name) from other Diseases
- In this section you will outline the conditions or diseases that may often be confused with the disease you are describing.
- You can list the diseases, include major clinical features of each differential diagnosis including major symptoms, physical exam findings, and provide a brief description of how each disease is different from the one you are describing, as seen here.
- You can differentiate physical examination characteristics from those of similar diseases.
- You can also provide guidance on the distinguishing characteristics of the physical exam findings, the laboratory findings, and other diagnostic modalities.
- A table may be helpful. It should be preceded by the following sentence:
The table below summarizes the findings that differentiate ______ dz from other conditions that may cause ____ (major symptoms) and _____ (major signs):
- If you want to have some abbreviations, you should describe them before starting the table. You can find an example here.
- The use of the following symbols may be helpful within a table:
- ↑ and ↓ ,to signify elevations and reductions in quantitative findings.
- + , ++, or +++ to signify varying levels of quantitative findings, – if there is a null value, and Nl if the desired value is within normal limits.
- The following table may be used as a general template for differentiating diseases from one another:
| Diseases | Laboratory Findings | Physical Examination | History and Symptoms | Other Findings | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lab Test 1 | Lab Test 2 | Lab Test 3 | Lab Test 4 | Physical Finding 1 | Physical Finding 2 | Physical Finding 3 | Physical Finding 4 | Finding 1 | Finding 2 | Finding 3 | Finding 4 | ||
| Differential Diagnosis 1 | + | ||||||||||||
| Differential Diagnosis 2 | ↑ | – | |||||||||||
| Differential Diagnosis 3 | ↓ | ||||||||||||
| Differential Diagnosis 4 | |||||||||||||
| Differential Diagnosis 5 | |||||||||||||
- This table must include the cardinal manifestations of differential diagnosis and the list of diseases must be prioritize based on mortality rate and prevalences of the diseases. For example, if you want to write a differential diagnosis table for heat stroke, sepsis, malignant hyperthermia, neuroleptic malignant syndrome, and serotonin syndrome first, you need to mention the cardinal manifestations for these conditions as, hyperthermia and altered mental status. Second, prioritize your list based on disease mortality or prevalence then, create the table. You can find the example here.
| Differential Diagnosis | Similar Features | Differentiating Features |
|---|---|---|
| Differential 1 |
|
|
| Differential 2 |
|
|
| Differential 3 |
|
|
| Differential 4 |
|
|
| Differential 5 |
|
|
Examples:
The following tables may be used as examples of different table styles for differentiating disease:
Example 1
The table below summarizes the different findings between Pericarditis and Myocardial infarction:
| Characteristic/Parameter | Pericarditis | Myocardial infarction |
|---|---|---|
| Pain description | Sharp, pleuritic, retro-sternal (under the sternum) or left precordial (left chest) pain. | Crushing, pressure-like, heavy pain. Described as “elephant on the chest”. |
| Radiation | Pain radiates to the trapezius ridge (to the lowest portion of the scapula on the back) or no radiation. | Pain radiates to the jaw, or the left or arm, or does not radiate. |
| Exertion | Does not change the pain | Can increase the pain |
| Position | Pain is worse supine or upon inspiration (breathing in) | Not positional |
| Onset/duration | Sudden pain, that lasts for hours or sometimes days before a patient comes to the ER | Sudden or chronically worsening pain that can come and go in paroxysms or it can last for hours before the patient decides to come to the ER |
Example 2
The table below summarizes the findings that differentiate Shigellosis from other conditions that cause fever and hemorrhage:
| Disease | Findings |
|---|---|
| EHEC | May present with fever, chills vomiting, diarrhea, generalized pain or malaise, and gastointestinal bleeding that follow an incubation period of 3-7 days. Unlike E. coli, Shigella cannot ferment lactose or decarboxylate lysine.[1] |
| Ebola | Presents with fever, chills vomiting, diarrhea, generalized pain or malaise, and sometimes internal and external bleeding, that follow an incubation period of 2-21 days. |
| Typhoid fever | Presents with fever, headache, rash, gastrointestinal symptoms, with lymphadenopathy, relative bradycardia, cough and leucopenia and sometimes sore throat. Blood and stool culture can confirm the presence of the causative bacteria. |
| Malaria | Presents with acute fever, headache and sometimes diarrhea (children). A blood smears must be examined for malaria parasites. The presence of parasites does not exclude a concurrent viral infection. An antimalarial should be prescribed as an empiric therapy. |
| Lassa fever | Disease onset is usually gradual, with fever, sore throat, cough, pharyngitis, and facial edema in the later stages. Inflammation and exudation of the pharynx and conjunctiva are common. |
| Yellow fever and other Flaviviridae | Present with hemorrhagic complications. Epidemiological investigation may reveal a pattern of disease transmission by an insect vector. Virus isolation and serological investigation serves to distinguish these viruses. Confirmed history of previous yellow fever vaccination will rule out yellow fever. |
| Others | Viral hepatitis, leptospirosis, rheumatic fever, typhus, and mononucleosis can produce signs and symptoms that may be confused with Ebola in the early stages of infection. |
Example 3
Stroke, must be differentiated from other diseases that may cause, altered mental status, motor and or somatosensory deficits. The table below, summarizes the differential diagnosis for stroke.
| Diseases | Symptoms | Physical Examination | Past medical history | Diagnostic tests | Other Findings | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Headache | ↓LOC | Motor weakness | Abnormal sensory | Motor Deficit | Sensory deficit | Speech difficulty | Gait abnormality | Cranial nerves | CT /MRI | CSF Findings | Gold standard test | |||
| Brain tumor[2] | + | – | – | – | + | + | + | – | + | Weight loss, fatigue | + | Cancer cells[3] | MRI | Cachexia, gradual progression of symptoms |
| Hemorrhagic stroke | + | + | + | + | + | + | + | + | – | Hypertension | + | – | CT scan without contrast[4][5] | Neck stiffness |
| Subdural hemorrhage | + | + | + | + | + | – | – | – | + | Trauma, fall | + | Xanthochromia[6] | CT scan without contrast[4][5] | Confusion, dizziness, nausea, vomiting |
| Neurosyphilis[7][8] | + | – | + | + | + | + | – | + | – | STIs | + | ↑ Leukocytes and protein | CSF VDRL-specifc
CSF FTA-Ab -sensitive[9] |
Blindness, confusion, depression,
Abnormal gait |
| Complex or atypical migraine | + | – | + | + | – | – | + | – | – | Family history of migraine | – | – | Clinical assesment | Presence of aura, nausea, vomiting |
| Hypertensive encephalopathy | + | + | – | – | – | – | + | + | – | Hypertension | + | – | Clinical assesment | Delirium, cortical blindness, cerebral edema, seizure |
| Wernicke’s encephalopathy | – | + | – | – | – | + | + | + | + | History of alcohal abuse | – | – | Clinical assesment and lab findings | Ophthalmoplegia, confusion |
| CNS abscess | + | + | – | – | + | + | + | – | – | History of drug abuse, endocarditis, immunosupression | + | ↑ leukocytes, ↓ glucose and ↑ protien | MRI is more sensitive and specific | High grade fever, fatigue,nausea, vomiting |
| Drug toxicity | – | + | – | + | + | + | – | + | – | – | – | – | Drug screen test | Lithium, Sedatives, phenytoin, carbamazepine |
| Conversion disorder | + | + | + | + | + | + | + | + | History of emotional stress | – | – | Diagnosis of exclusion | Tremors, blindness, difficulty swallowing | |
| Metabolic disturbances (electrolyte imbalance, hypoglycemia) | – | + | + | + | + | + | – | – | + | – | – | Hypoglycemia, hypo and hypernatremia, hypo and hyperkalemia | Depends on the cause | Confusion, seizure, palpitations, sweating, dizziness, hypoglycemia |
| Meningitis or encephalitis | + | – | – | – | – | + | + | – | – | History of fever and malaise | – | ↑ Leukocytes,
↑ Protein ↓ Glucose |
CSF analysis[10] | Fever, neck |
| Multiple sclerosis exacerbation | – | – | + | + | – | + | + | + | + | History of relapses and remissions | + | ↑ CSF IgG levels
(monoclonal bands) |
Clinical assesment and MRI [11] | Blurry vision, urinary incontinence, fatigue |
| Seizure | + | + | – | – | + | + | – | – | + | Previous history of seizures | – | Mass lesion | Clinical assesment and EEG [12] | Confusion, apathy, irritability, |
References
- References should be cited for the material that you have put on your page. Type in {{reflist|2}}.This will generate your references in small font, in two columns, with links to the original article and abstract.
- For information on how to add references into your page, click here
- ↑ Hale, TL; Keusch, GT (1996). “Shigella. In: Baron S, editor. Medical Microbiology. 4th edition”. Galveston (TX): University of Texas Medical Branch at Galveston. Retrieved 4 April 2015.
- ↑ Morgenstern LB, Frankowski RF (1999). “Brain tumor masquerading as stroke”. J Neurooncol. 44 (1): 47–52. PMID 10582668.
- ↑ Weston CL, Glantz MJ, Connor JR (2011). “Detection of cancer cells in the cerebrospinal fluid: current methods and future directions”. Fluids Barriers CNS. 8 (1): 14. doi:10.1186/2045-8118-8-14. PMC 3059292. PMID 21371327.
- ↑ 4.0 4.1 Birenbaum D, Bancroft LW, Felsberg GJ (2011). “Imaging in acute stroke”. West J Emerg Med. 12 (1): 67–76. PMC 3088377. PMID 21694755.
- ↑ 5.0 5.1 DeLaPaz RL, Wippold FJ, Cornelius RS, Amin-Hanjani S, Angtuaco EJ, Broderick DF; et al. (2011). “ACR Appropriateness Criteria® on cerebrovascular disease”. J Am Coll Radiol. 8 (8): 532–8. doi:10.1016/j.jacr.2011.05.010. PMID 21807345.
- ↑ Lee MC, Heaney LM, Jacobson RL, Klassen AC (1975). “Cerebrospinal fluid in cerebral hemorrhage and infarction”. Stroke. 6 (6): 638–41. PMID 1198628.
- ↑ Liu LL, Zheng WH, Tong ML, Liu GL, Zhang HL, Fu ZG; et al. (2012). “Ischemic stroke as a primary symptom of neurosyphilis among HIV-negative emergency patients”. J Neurol Sci. 317 (1–2): 35–9. doi:10.1016/j.jns.2012.03.003. PMID 22482824.
- ↑ Berger JR, Dean D (2014). “Neurosyphilis”. Handb Clin Neurol. 121: 1461–72. doi:10.1016/B978-0-7020-4088-7.00098-5. PMID 24365430.
- ↑ Ho EL, Marra CM (2012). “Treponemal tests for neurosyphilis–less accurate than what we thought?”. Sex Transm Dis. 39 (4): 298–9. doi:10.1097/OLQ.0b013e31824ee574. PMC 3746559. PMID 22421697.
- ↑ Carbonnelle E (2009). “[Laboratory diagnosis of bacterial meningitis: usefulness of various tests for the determination of the etiological agent]”. Med Mal Infect. 39 (7–8): 581–605. doi:10.1016/j.medmal.2009.02.017. PMID 19398286.
- ↑ Giang DW, Grow VM, Mooney C, Mushlin AI, Goodman AD, Mattson DH; et al. (1994). “Clinical diagnosis of multiple sclerosis. The impact of magnetic resonance imaging and ancillary testing. Rochester-Toronto Magnetic Resonance Study Group”. Arch Neurol. 51 (1): 61–6. PMID 8274111.
- ↑ Manford M (2001). “Assessment and investigation of possible epileptic seizures”. J Neurol Neurosurg Psychiatry. 70 Suppl 2: II3–8. PMC 1765557. PMID 11385043.
Epidemiology and Demographics
- Myoglobinuria in adults is caused most commonly by trauma, alcohol and drug abuse, usually in relation to muscle necrosis from prolonged immobilization and pressure by the body weight. Protracted consumption of alcohol, seizure activity or vigorous physical activity, can also lead to a disequilibrium between muscle energy consumption and production, resulting in muscle destruction. [1] [2]
- Myoglobinuria in children and adolescents, is caused most commonly by viral myositis, trauma, exertion, drug overdose, seizures, metabolic disorders, and connective tissue diseases.[3]
Race
Race is a factor only when natural disasters and economic shortfalls increase the rates of drug and alcohol abuse and the mortality rate among certain racial groups.
Sex
Myoglobinuria tends to affect males more than females because males are more predisposed to trauma and participation in strenuous physical exercise. Persons who exercise and have increased muscle mass have an increased intracellular myoglobin content.
Age
The median age for myoglobinuria is children and adolescents is 11 years. The leading cause of rhabdomyolysis in the 0-9 year age range is viral myositis, whereas the leading cause in the 9-18 year age range is trauma. [4]
References
- ↑ Sauret JM, Marinides G, Wang GK (2002). “Rhabdomyolysis”. Am Fam Physician. 65 (5): 907–12. PMID 11898964.
- ↑ Line RL, Rust GS (1995). “Acute exertional rhabdomyolysis”. Am Fam Physician. 52 (2): 502–6. PMID 7625324.
- ↑ Moghtader J, Brady WJ, Bonadio W (1997). “Exertional rhabdomyolysis in an adolescent athlete”. Pediatr Emerg Care. 13 (6): 382–5. PMID 9434995.
- ↑ Lim YS, Cho H, Lee ST, Lee Y (2018). “Acute kidney injury in pediatric patients with rhabdomyolysis”. Korean J Pediatr. 61 (3): 95–100. doi:10.3345/kjp.2018.61.3.95. PMC 5876511. PMID 29628970.
Natural History, Complications and Prognosis
Natural History Myoglobinuria does not lead to death, unless it is associated with the secondary complications of rhabdomyolysis, including hyperkalemia, hypocalcemia, and acute kidney injury.[1] However, when it is associated with severe rhabdomyolysis, myoglobinuria-induced acute renal failure is a potentially lethal complication.
Complications’ and Prognosis In adults, myoglobinuria, due to rhabdomyolysis can be complicated by acute kidney injury, that requires hemodyalisis. In children, renal failure and acute kidney injury are also the most common complications.
- ↑ Petejova N, Martinek A (2014). “Acute kidney injury due to rhabdomyolysis and renal replacement therapy: a critical review”. Crit Care. 18 (3): 224. doi:10.1186/cc13897. PMC 4056317. PMID 25043142.
Diagnosis
Diagnosis
Diagnostic study of choice | History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | X-Ray Findings | Echocardiography and Ultrasound | CT-Scan Findings | MRI Findings | Other Imaging Findings | Other Diagnostic Studies
Treatment
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH
